Search results for "HPV"
Cost-effectiveness of HPV vaccination after age 26 low, varies by risk factors
A model found that human papillomavirus (HPV) vaccination of men and women ages 27 to 45 years cost $2,005,000 per quality-adjusted life-year gained. Vaccinating patients in this age range who had more partners or had recently left a relationship was more cost-effective.
https://immattersacp.org/weekly/archives/2024/12/03/1.htm
3 Dec 2024
Raising awareness about HPV-related cancers
The human papillomavirus (HPV) vaccine can potentially prevent more than 90% of HPV-associated cancers. Generally given to teens, it can be offered to adults as well.
https://immattersacp.org/archives/2023/10/raising-awareness-about-hpv-related-cancers.htm
1 Oct 2023
Home-based HPV screening appears cost-effective, study finds
In an economic evaluation of 19,851 female participants from a randomized clinical trial, incremental cost-effectiveness ratios for increased uptake of human papillomavirus (HPV) screening ranged from $86 to $146 per additional screening completed.
https://immattersacp.org/weekly/archives/2023/03/28/4.htm
28 Mar 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2025/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2025
Decrease in certain HPV types among unvaccinated women suggests herd protection
Prevalence of the four types of human papillomavirus (HPV) included in the original vaccine decreased most among women who were fully vaccinated but also decreased significantly among women who were unvaccinated between 2006 and 2017.
https://immattersacp.org/weekly/archives/2019/01/29/4.htm
29 Jan 2019
HPV vaccine impacts disease, screening
While HPV immunization is recommended during adolescence, internists practicing in the postvaccine era have their own host of considerations: namely, screening for cervical cancer and providing catch-up vaccination.
https://immattersacp.org/archives/2017/02/hpv.htm
1 Feb 2017
Little health benefit, higher costs likely with extended age limit for HPV vaccination
A modeling study examined four scenarios for extended vaccination in women and men up to ages 26, 30, 40, and 45 years.
https://immattersacp.org/weekly/archives/2019/12/10/1.htm
10 Dec 2019
HPV vaccine efficacy increases, but use lags
Human papillomavirus immunization rates continue, for several reasons, to lag behind those of other vaccines. Experts are formulating new approaches for physicians and patients to ensure that HPV protection is as robust as possible.
https://immattersacp.org/archives/2016/02/HPV.htm
1 Feb 2016
CDC recommends change to HPV vaccination schedule
Three doses had previously been recommended, but studies have suggested that 2 doses are just as effective in children who begin vaccination before age 15, the CDC's Advisory Committee on Immunization Practices decided.
https://immattersacp.org/weekly/archives/2016/10/25/5.htm
25 Oct 2016
Troubleshooting tips for cervical cancer screening
Two experts advise physicians on cervical cancer screening, dealing with issues from sampling technique to confusing guidelines.
https://immattersacp.org/archives/2024/07/troubleshooting-tips-for-cervical-cancer-screening.htm
1 Jul 2024